Report of Foreign Issuer (6-k)
April 17 2018 - 2:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2018
Commission File Number:
001-32001
Aptose Biosciences Inc.
(Translation of registrant's name into English)
5955 Airport Road, Suite 228
Mississauga, ON
L4V 1R9
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ ] Form 40-F [ X ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
On April 17, 2018, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
(c)
Exhibit 99.1
. Press release dated April 17, 2018
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Aptose Biosciences Inc.
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date: April 17, 2018
|
|
/s/ Gregory K. Chow
|
|
|
Gregory K. Chow
|
|
|
Senior Vice President and Chief Financial Officer
|
|
|
|
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Sep 2023 to Sep 2024